Bio Rad Laboratories, Inc. financial data

Symbol
BIO, BIO-B on NYSE
Industry
Laboratory Analytical Instruments
Location
1000 Alfred Nobel Drive, Hercules, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 582 % +6.34%
Quick Ratio 146 % +21.8%
Debt-to-equity 40.8 % -1%
Return On Assets -2.64 % -79.4%
Operating Margin 12.3 % -14.1%

Shares

Label TTM Value / Value Unit Change %
Weighted Average Number of Shares Outstanding, Basic 28.5 M shares -3.64%
Weighted Average Number of Shares Outstanding, Diluted 28.5 M shares -4.07%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 2.61 B USD -6.25%
Research and Development Expense 239 M USD -12.3%
Operating Income (Loss) 321 M USD -19.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -444 M USD -76.5%
Income Tax Expense (Benefit) -121 M USD -102%
Net Income (Loss) Attributable to Parent -322 M USD -68.6%
Earnings Per Share, Basic -10.3 USD/shares -63.7%
Earnings Per Share, Diluted -10.4 USD/shares -61.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 433 M USD -6.65%
Accounts Receivable, after Allowance for Credit Loss, Current 445 M USD -10.7%
Inventory, Net 783 M USD +4.04%
Other Assets, Current 38.8 M USD -19.5%
Assets, Current 3.06 B USD -6.6%
Property, Plant and Equipment, Net 529 M USD +6.1%
Operating Lease, Right-of-Use Asset 189 M USD +8.51%
Intangible Assets, Net (Excluding Goodwill) 314 M USD -4.34%
Goodwill 413 M USD +1.24%
Other Assets, Noncurrent 94.9 M USD +0.27%
Assets 12.6 B USD -7.74%
Accounts Payable, Current 103 M USD -36.2%
Employee-related Liabilities, Current 146 M USD -15.8%
Liabilities, Current 466 M USD -20.9%
Long-term Debt and Lease Obligation 1.2 B USD +0.11%
Deferred Income Tax Liabilities, Net 1.54 B USD -12.9%
Operating Lease, Liability, Noncurrent 160 M USD +8.69%
Other Liabilities, Noncurrent 192 M USD -3.43%
Liabilities 3.56 B USD -8.84%
Accumulated Other Comprehensive Income (Loss), Net of Tax -426 M USD -4.32%
Retained Earnings (Accumulated Deficit) 9.64 B USD -3.24%
Stockholders' Equity Attributable to Parent 9.05 B USD -7.3%
Liabilities and Equity 12.6 B USD -7.74%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 69.8 M USD -28.9%
Net Cash Provided by (Used in) Financing Activities -426 M USD -144%
Net Cash Provided by (Used in) Investing Activities -43.1 M USD +38.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 29.4 M USD -1.92%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 434 M USD -6.62%
Interest Paid, Excluding Capitalized Interest, Operating Activities 22.4 M USD -0.25%
Deferred Tax Assets, Valuation Allowance 53.2 M USD -26.9%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 264 M USD -1.75%
Operating Lease, Liability 200 M USD +9.12%
Payments to Acquire Property, Plant, and Equipment 40.2 M USD +12.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -507 M USD +87.1%
Lessee, Operating Lease, Liability, to be Paid 229 M USD +11.3%
Property, Plant and Equipment, Gross 1.6 B USD +5.82%
Operating Lease, Liability, Current 40 M USD +10.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 34.7 M USD +3.27%
Lessee, Operating Lease, Liability, to be Paid, Year One 46.2 M USD +24.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +32.3%
Deferred Income Tax Expense (Benefit) -323 M USD +74%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 29.2 M USD +28.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 27.1 M USD +3.04%
Deferred Federal Income Tax Expense (Benefit) -292 M USD +74%
Current Income Tax Expense (Benefit) 103 M USD -34.3%
Preferred Stock, Shares Authorized 7.5 M shares 0%
Unrecognized Tax Benefits 86.1 M USD -1.26%
Lessee, Operating Lease, Liability, to be Paid, Year Four 21.5 M USD +1.9%
Operating Lease, Payments 42 M USD +9.09%
Additional Paid in Capital 463 M USD -0.17%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 12 M USD -40.3%
Current Federal Tax Expense (Benefit) 73.8 M USD -34.6%
Amortization of Intangible Assets 23.3 M USD -5.29%
Depreciation, Depletion and Amortization 146 M USD +6.26%
Deferred Tax Assets, Net of Valuation Allowance 211 M USD +7.61%
Share-based Payment Arrangement, Expense 61.3 M USD +0.66%
Deferred State and Local Income Tax Expense (Benefit) -15.7 M USD +81.2%
Interest Expense 49.4 M USD +6.41%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%